Biotech Company Owns Clinical Trial Property Held by CRO

By Jason M. Brocks, Legal Analyst,Bloomberg Law

A recent U.S. District Court decision emphasizes the importance to research sponsors and contract research organizations(CROs) of understanding the terms set out in their agreements, particularly those terms relating to the responsibilities of each party upon termination of the arrangement.

Pharmaceutical, medical device and biotechnology companies that sponsor clinical research regularly rely on CROs to administer and monitor clinical trials because sponsors themselves are insufficiently equipped to perform these tasks.

 

Read More >>>

Bloomberg BRIEF Newsletters